Insiders · FTH

Christopher Gerry

President & PEO at Sensei Biotherapeutics, Inc. (FTH) since November 2025

Christopher Gerry has filed 2 insider reports with the SEC since November 2025, as president & PEO at Sensei Biotherapeutics, Inc. (FTH). The latest filing, on June 13, 2026, reports grant or award at Sensei Biotherapeutics, Inc. (FTH).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Christopher Gerry is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Sensei Biotherapeutics, Inc. logo
FTH
Sensei Biotherapeutics, Inc.
President & PEOsince November 20251,574$7.88Jun 13, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Christopher Gerry with

Other insiders at the same companies

Questions about Christopher Gerry

What is Christopher Gerry's role at Sensei Biotherapeutics, Inc.?
Christopher Gerry reports to the SEC as president & PEO at Sensei Biotherapeutics, Inc. (FTH), according to the latest filing on June 13, 2026.
How many shares does Christopher Gerry own?
After the latest filing that states it, Christopher Gerry directly owned 1,574 shares of Sensei Biotherapeutics, Inc. (FTH). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Christopher Gerry bought or sold stock recently?
No open-market purchases or sales by Christopher Gerry are on file. The filings report grant or award.
How do I get alerts when Christopher Gerry files?
Follow Christopher Gerry on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Christopher Gerry (SEC CIK 0002097951). Totals count each trade once, skipping amendments whose original is on file, from Nov 25, 2025 on. View on SEC EDGAR · Get this as JSON